A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

In this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported. Emphasis is given on recent results about a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Papakonstantinou, Vasiliki D., Lagopati, Nefeli, Tsilibary, Effie C., Demopoulos, Constantinos A., Philippopoulos, Athanassios I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387815/
https://www.ncbi.nlm.nih.gov/pubmed/28458618
http://dx.doi.org/10.1155/2017/6947034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387815/
https://www.ncbi.nlm.nih.gov/pubmed/28458618
http://dx.doi.org/10.1155/2017/6947034

Ejemplares similares